Published

Psilocybin desynchronizes the human brain.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Nature
Date: 2024-08-01
Source: PubMed
DOI: 10.1038/s41586-024-07624-5
PubMed: 39020167

Derived topics and classifications

psilocybin Neuroplasticity Brain Imaging Default Mode Network Aging Clinical Trial Animal Study Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 17 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”2026-06-30 Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex2026-06-28 DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish2026-06-18 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex2026-06-01 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache2026-05-29 Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report2026-05-28 Human brain changes after first psilocybin use2026-05-05 Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms2026-05-01 A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder2026-05-01 Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors2026-03-26 Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26 PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS2026-03-19 Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies2026-03-19 Pilot study of psilocybin in patients with post-treatment lyme disease2026-02-25 The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior2026-02-01 Psilocybin desynchronizes the human brain.2024-08-01

Related papers

The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-07-30 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical TrialClinicalTrials.gov · 2026-07-28 PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical TrialClinicalTrials.gov · 2026-07-10 Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17